The role of Injury signals in RPE Reprogramming

损伤信号在 RPE 重编程中的作用

• 批准号: 9129196
• 负责人: Katia Del Rio-Tsonis
• 金额: $ 36.13万
• 依托单位: MIAMI UNIVERSITY OXFORD
• 依托单位国家: 美国
• 财政年份: 2016
• 资助国家: 美国
• 起止时间: 2016-04-01 至 2021-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9129196
• 关键词: Age related macular degeneration; Animal Model; Antioxidants; Back; Biological Models; Blindness; Cells; Chick Embryo; Complement; Complement 3a; Complement 5a; Cysteine; Data; Diabetic Retinopathy; Disease; Embryo; Epigenetic Process; Epithelial; Epithelium; Excision; Exhibits; Eye; FGF2 gene; Fibroblast Growth Factor; Figs - dietary; Gene Targeting; Genes; Genetic; Glaucoma; Goals; Growth; Human; Inflammation; Injury; Interleukin-6; Knowledge; Lead; MAP Kinase Gene; Mammals; Mesenchymal; Molecular; Natural regeneration; Neural Retina; Neurons; Outcome; Oxidation-Reduction; Pathway interactions; Phase; Play; Process; Proliferating; Publishing; Reactive Oxygen Species; Regenerative Medicine; Research; Retina; Role; Signal Pathway; Signal Transduction; Staging; Stem cells; Structure of retinal pigment epithelium; Testing; Up-Regulation; Vision; Visual impairment; Visual system structure; Work; cell type; cytokine; injured; innovation; methylome; neuroepithelium; neuron loss; public health relevance; receptor coupling; regenerative; regenerative therapy; relating to nervous system; repaired; retinal neuron; small molecule; stem; tissue regeneration; transcriptome sequencing; transdifferentiation

 DESCRIPTION (provided by applicant): The leading causes of blindness and low vision in the US include AMD, diabetic retinopathy and glaucoma. Current therapies offer few options to those suffering from late stages of these diseases. In order to explore possible therapies, it is important to use animal models with regenerative capabilities such as the chick embryo. Embryonic chicks regenerate their retina, following retinectomy, by reprogramming the remaining retinal pigmented epithelium (RPE) as long as an inducing factor is present. This reprogramming process allows the RPE to dedifferentiate, proliferate and form a neuro-epithelium that eventually differentiates generating retina. The process of dedifferentiation is ke to understanding how RPE reprogramming works. RPE reprogramming utilizes a two-step dedifferentiation process where injury (retinectomy) stimulates the RPE to become competent to respond to inducing factors. We have identified several inducing factors that are able to reprogram the RPE to neural retina, however, the role for these molecules in RPE reprogramming remains unknown. In this proposal we will dissect the mechanisms by which inducing factors such complement components C3a, C5a and inflammation associated molecules including IL-6 and antioxidant N-acetyl cysteine (NAC) reprogram the RPE. Specifically, we will explore if these factors/molecules exhibit interdependence, if they require common signaling pathways or if they regulate common target genes using similar or distinct epigenetic strategies. We will test the following hypothesis: Inducing factors direct RPE reprogramming and retina regeneration by initiating downstream signaling cascades such as MAPK, PI3K, Wnt and/or Jak/Stat pathways commonly activated by growth factor and G-coupled receptors. Through these pathways, the inducing factors epigenetically control common genes that regulate RPE reprogramming. The urgency for restoring vision lead the NEI to announce an audacious goal "to restore vision through regeneration of neurons and neural connections in the eye and visual system". This study provides a model system where to test small molecules such as C3a, C5a, IL-6 and NAC to evaluate induction of retina regeneration and a platform where to dissect the cellular and molecular mechanisms involved in this process. This work will have a significant impact on the field of regenerative medicine since the information obtained can be extrapolated to the process of retina repair in mammals including humans, and specifically on the potential reprogramming of human RPE to generate new neurons.

 描述（由申请人提供）：美国失明和低视力的主要原因包括AMD、糖尿病视网膜病变和青光眼。目前的治疗方法为这些疾病晚期患者提供的选择很少。为了探索可能的治疗方法，重要的是使用具有再生能力的动物模型，如鸡胚。只要存在诱导因子，胚胎鸡在视网膜切除术后通过重新编程剩余的视网膜色素上皮（RPE）来再生其视网膜。这种重编程过程允许RPE去分化、增殖并形成最终分化产生视网膜的神经上皮。去分化过程有助于理解RPE重编程的工作原理。RPE重编程利用两步去分化过程，其中损伤（视网膜切除术）刺激RPE变得有能力响应诱导因子。我们已经鉴定了几种能够将RPE重编程为神经视网膜的诱导因子，然而，这些分子在RPE重编程中的作用仍然未知。在本研究中，我们将分析诱导因子如补体成分C3 a、C5 a和炎症相关分子包括IL-6和抗氧化剂N-乙酰半胱氨酸（NAC）对RPE重编程的机制。具体来说，我们将探讨这些因素/分子是否表现出相互依赖性，它们是否需要共同的信号通路，或者它们是否使用相似或不同的表观遗传策略调节共同的靶基因。我们将检验以下假设：诱导因素通过启动下游信号级联反应（例如通常由生长因子和G偶联受体激活的MAPK、PI 3 K、Wnt和/或Jak/Stat途径）来指导RPE重编程和视网膜再生。通过这些途径，诱导因子表观遗传地控制调节RPE重编程的共同基因。恢复视力的紧迫性导致NEI宣布了一个大胆的目标“通过眼睛和视觉系统中的神经元和神经连接的再生来恢复视力”。这项研究提供了一个模型系统，其中测试小分子，如C3 a，C5 a，IL-6和NAC，以评估视网膜再生的诱导和一个平台，其中剖析参与这一过程的细胞和分子机制。这项工作将对再生医学领域产生重大影响，因为所获得的信息可以外推到包括人类在内的哺乳动物的视网膜修复过程，特别是人类RPE的潜在重编程以产生新的神经元。